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Splenomegaly is an uncommon presenting feature of non-Hodgkin’s lymphoma. This is a study of 16 cases of non-Hodgkin’s lymphoma 
presenting with prominent splenomegaly, which includes ten B-cell lymphomas and six T-cell lymphomas. There were distinct clinical and 
morphologic differences between these two immunologic types of splenic lymphomas, the B-cell types being predominantly low grade and 
occurring in older individuals whereas the T-cell lymphomas were predominantly high grade and occurred in adolescents and young 
adults. 
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Splenomegaly is not generally the presenting feature in 
patients with non-Hodgkin’s lymphoma though it may be 
found during the course of the disease (1-5). Various 
criteria have been used for the diagnosis of primary malig- 
nant lymphoma of the spleen (6-9) and so the term 
‘lymphoma with prominent splenomegaly’ is preferred ( 10. 
11). 
MATERIAL AND METHODS 
We have studied 16 patients with non-Hodgkin’s 
lymphoma who presented with prominent splenomegaly 
during a period of eleven and a half years (January 1985 to 
July 1996). All cases were principally confined to the 
spleen and its regional lymph nodes with or without 
involvement of liver and bone marrow but without periph- 
eral lymphadenopathy. 
Relevant clinical data were obtained from hospital and 
biopsy records. Tissue was processed routinely and 5 p 
sections were stained with haematoxylin and eosin. Im- 
munostaining was performed on paraffin sections by using 
the avidin-biotin-peroxidase technique and developed 
with diaminobenzidine. The antisera used included CD20 
(L26) and CD79a as B-cell markers and CD45RO 
(UCHLI) and poly CD3 as T-cell markers. All markers 
were obtained from DAKO except for CD79a which was a 
gift from Professor D.Y. Mason, John Radcliffe Hospital, 
Oxford. The cases were categorized according to the up- 
dated Kiel classification (12) and when possible entities 
described in the REAL scheme (13) were diagnosed. 
In addition to spleens, lymph nodes were available for 
study in 8 cases, liver biopsies in 7 and bone marrow 
aspirates and/or biopsies in 13 cases. 
RESULTS 
Sixteen cases of non-Hodgkin’s lymphoma presented with 
splenomegaly, constituting 1.04% of all non-Hodgkin’s 
lymphomas during the study period. Based on immunohis- 
tochemical analysis they were categorized as B-cell 
lymphomas in 10 cases and T-cell lymphomas in 6 cases. 
These were separately analysed as they had distinct clinico- 
pathologic features. 
B-cell lymphoma: 
All 10 cases were males with an age ranging from 45 to 70 
years (mean 56.38 years). They presented with 
splenomegaly (10 cases), cytopaenias (8 cases) or ‘B-symp- 
toms’ such as fever, weight loss, and fatigue (4 cases). The 
spleen was available for gross study in 9 cases. Moderate 
to massive splenomegaly with splenic weights ranging from 
300 to 3700 g (mean 1430 g) was found. Cut sections 
showed uniformly distributed miliary nodules (Fig. 1). 
Bone marrow involvement was present in 5j8 cases and 
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regional lymph nodes were involved in another 5 / 8  cases 
(including small mesenteric nodes in 2 cases). There was no 
involvement of peripheral blood at presentation except for 
one case of marginal zone lymphoma. 
Histologic classification according to Kiel classification 
showed 9 low-grade and one high-grade lymphoma (cen- 
troblastic lymphoma). The low-grade lymphomas included 
8 centrocytic and one lymphoplasmacytic type. Of the 
centrocytic lymphomas, 7 were of the mantle cell type as 
described in the REAL scheme. In these cases there was a 
nodular pattern of involvement mainly confined to the 
white pulp with minimal involvement of red pulp (Fig. 2). 
They were composed of a monotonous population of small 
cells with irregular nuclei (Fig. 3). One case was of the 
marginal zone type, with widely spaced centrocytes inter- 
mixed with plasma cells and occasional centroblasts. This 
case was associated with abnormal lymphoid cells with 
hairy projections in the bone marrow smear and reactive 
lymphoid cells in the peripheral smear. The cells did not 
stain for tartarate resistent acid phosphatase. The single 
case of lymphoplasmacytic lymphoma showed diffuse 
infiltration of red as well as white pulp by tumour. One 
case of centroblastic lymphoma showed localized tumour 
with involvement of both white and red pulp by centrob- 
lasts. 
T-cell lymphoma: 
Of the 6 cases belonging to this category 5 were males with 
an age ranging from 12 to 30 years (mean 21.7 years). All 
presented with fever and splenomegaly and three with 
bleeding due to throbocytopaenia. Bone marrow and liver 
involvement was present in all 5 cases (in one case, an 
outside referral, these details were not recorded). 
Fig. 2. Mantle cell lymphoma: nodular pattern due to confi- 
nement to the white pulp and minimal involvement of the red 
pulp (H&E x 20). 
The weights of the spleens ranged from 308 to 4 100 g 
and their cut surfaces showed diffuse congestion. Histolog- 
ically they were all peripheral T-cell lymphomas, 5 pre- 
dominantly large cell type and one pleomorphic small cell 
type. 
DISCUSSION 
Non-Hodgkin’s lymphomas presenting with splenomegaly 
are quite rare, only amounting to about 1-2% of all 
lymphomas (11). (It constituted only 1.04% of all 
lymphomas in our study). Non-Hodgkin’s lymphomas 
arising primarily in the spleen remain principally confined 
to the spleen and its local lymph nodes. The disease may 
then spread from this area to more distant sites, such as 
other abdominal lymph nodes, liver or bone marrow. 
Peripheral adenopathy is either not existent or may repre- 
sent a very late seeding from the spleen (6). 
Fig. 1. Cut section of spleen showing uniformly distributed mil- 
iary nodules. 
Fig. 3. Mantle cell lymphoma: montonous population of small 
cells with irregular nuclei (H&E x 400). 
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Most previous reports indicate predominance of low- 
grade B-cell lymphomas ( 8 -  1 I ) .  A small number of T-cell 
lymphomas of the spleen have also been reported (8. 1 I ,  
14). This study also shows a predominance of low-grade 
B-cell lymphomas over T-cell types. Among the low-grade 
B-cell lymphomas a majority was of the mantle cell type as 
described in  recent literature (10, 1 1 ) .  In one case of 
splenic marginal zone lymphoma villous lymphocytes were 
detected on bone marrow aspirate and imprints from the 
spleen. This was consistent with the entity SLVL (splenic 
lymphoma with villous lymphocytes) as described in litera- 
ture (15). 
Our study showed distinct clinical and morphologic 
differences between the two immunologcal types of splenic 
lymphomas. B-cell types were predominantly of low-grade 
and occurred in older individuals. whereas T-cell types, 
found in young adults and adolescents, were predomi- 
nantly of high-grade and with liver involvement. These 
high-grade T-cell lymphomas probably represent the hep- 
ato-splenic gamma delta T-cell lymphomas a s  described in 
literature (16). 
This material contains more aggressive lymphomas and 
more T-cell lymphomas than would be expected in indus- 
trialized countries. However, it fits in well with the pattern 
known from developing countries. 
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